M. Lebwohl, J. Sugarman, D. Pariser, J. Bagel, T. Lin, and R. Israel, “Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study”, J of Skin, vol. 4, no. 1, p. S12, Jan. 2020.